Jean Y. Perentes - Publications

Nodal Upstaging and Oncologic Outcomes After Segmentectomy Versus Lobectomy for Early-Stage Non-Small Cell Lung Cancer.

Journal: Cancers

Published: March 01, 2026

Outcomes After VATS Single Versus Multiple Segmentectomy for cT1N0 Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: October 25, 2025

Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapy.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 29, 2025

Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.

Journal: EMBO molecular medicine

Published: September 10, 2025

The value of positron emission tomography scan in predicting pathologic response of non-small cell lung cancer managed by neoadjuvant chemo-immunotherapy.

Journal: Journal of thoracic disease

Published: August 17, 2025

Post-operative volume changes in residual lung lobes after VATS pulmonary segmentectomy for early stage non-small cell lung cancer.

Journal: Journal of cardiothoracic surgery

Published: June 30, 2025

Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control.

Journal: Journal for immunotherapy of cancer

Published: May 21, 2025

Repeated Anatomical Pulmonary Resection for Second Primary Nonsmall-Cell Lung Cancer: Safety and Short-Term Outcomes.

Journal: Thoracic cancer

Published: May 12, 2025

Dual implication of endothelial adhesion molecules in tumor progression and cancer immunity.

Journal: Cell adhesion & migration

Published: March 12, 2025

Does surgical margin affect recurrence and survival after pulmonary segmentectomy for cT1 lung cancer?

Journal: Journal of thoracic disease

Published: February 17, 2025

Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis.

Journal: Cancer treatment and research communications

Published: October 14, 2024

Hyperthermic Intrathoracic Chemotherapy Modulates the Immune Microenvironment of Pleural Mesothelioma and Improves the Impact of Dual Immune Checkpoint Inhibition.

Journal: Cancer immunology research

Published: March 11, 2024